GO:0005882 intermediate filament: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005882 intermediate filament describes a 10 nm cytoplasmic cytoskeletal structure composed of chemically heterogeneous subunits that mechanically integrates the cytoplasmic space.
• Intermediate filaments are divided into five classes: Type I acidic keratins, Type II basic keratins, Type III desmin/vimentin and others, Type IV neurofilaments, and Type V lamins.
• Assembly is driven by coiled-coil dimerization, antiparallel tetramer formation, and lateral association into 10 nm filaments, with plectin and other cytolinkers mediating network integration.
• Intermediate filament proteins are reliable immunohistological biomarkers for multiple tissue-specific diseases, including myopathies and neuropathies.
• Mutations in intermediate filament genes cause tissue-specific diseases such as epidermolysis bullosa simplex, desmin-related myopathy, and laminopathies.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of intermediate filament gene function in disease and development.
Description
Intermediate filaments (IFs) are a major cytoskeletal system in eukaryotic cells, defined by GO:0005882 as a distinct elongated structure characteristically 10 nm in diameter that occurs in the cytoplasm and forms a fibrous network composed of chemically heterogeneous subunits. Unlike actin microfilaments and microtubules, IFs are non-polar, highly stable, and primarily mechanical in function, integrating the cytoplasmic space and providing resilience to mechanical stress. The IF superfamily is divided into five chemically distinct classes: Type I acidic keratins, Type II basic keratins, Type III including desmin and vimentin, Type IV neurofilaments and related filaments, and Type V lamins. This classification underpins the tissue-specific expression and disease associations of IF proteins. For researchers, GO:0005882 is a central node linking cell mechanics, tissue integrity, and human disease. IF proteins are reliable immunohistological biomarkers that help diagnose multiple tissue-specific diseases, including myopathies and neuropathies. Mutations in IF genes cause a wide spectrum of disorders, from skin blistering to muscular dystrophy and premature aging. Understanding IF assembly, dynamics, and regulation is therefore essential for both basic cell biology and translational research. This article provides a research-grade overview of GO:0005882, covering its definition, structure, assembly mechanism, key genes, disease links, and experimental methods including CRISPR-based models. All statements are grounded in the verified literature cited by number.
intermediate filament At A Glance
| GO ID | GO:0005882 |
|---|---|
| GO term | intermediate filament |
| Ontology | cellular_component |
| Synonym | intermediate filament associated protein; type II intermediate filament associated protein; type I intermediate filament associated protein |
| Major function | Mechanical integration of the cytoplasmic space and cellular resilience to stress |
| Diameter | Characteristically 10 nm |
| Subunit classes | Type I acidic keratins; Type II basic keratins; Type III desmin, vimentin and others; Type IV neurofilaments; Type V lamins |
| Assembly principle | Coiled-coil dimers, antiparallel tetramers, lateral association into 10 nm filaments |
| Key cytolinker | Plectin mediates IF network integration and functions |
What Is GO:0005882?
GO:0005882 intermediate filament is a cellular component ontology term describing a cytoskeletal structure that forms a distinct elongated structure, characteristically 10 nm in diameter, occurring in the cytoplasm of eukaryotic cells. Intermediate filaments form a fibrous system composed of chemically heterogeneous subunits and are involved in mechanically integrating the various components of the cytoplasmic space. They are divided into five chemically distinct classes: Type I acidic keratins; Type II basic keratins; Type III including desmin, vimentin and others; Type IV neurofilaments and related filaments; and Type V lamins.
Why Is intermediate filament Important in Cell Biology?
Intermediate filaments are essential for maintaining cell and tissue integrity, and their dysfunction is linked to a broad range of human diseases. Because IF proteins are tissue-specific and highly stable, they serve as reliable immunohistological biomarkers for diagnosing multiple tissue-specific diseases, including myopathies and neuropathies. Mutations in IF genes cause diseases such as epidermolysis bullosa simplex, desmin-related myopathy, and laminopathies, making GO:0005882 a critical term for both basic and clinical research.
• IFs provide mechanical resilience to cells and tissues, protecting against mechanical stress.
• IF proteins are reliable immunohistological biomarkers for tissue-specific diseases.
• Mutations in IF genes cause skin blistering, muscular dystrophy, and premature aging disorders.
• IFs integrate with other cytoskeletal systems via cytolinkers such as plectin.
• IF dynamics are regulated by phosphorylation and assembly-disassembly cycles.
• IFs are involved in cell signaling, organelle positioning, and stress responses.
• Type V lamins form the nuclear lamina and are implicated in laminopathies.
• Type IV neurofilaments are key structural components of axons and are linked to neurodegeneration.
• IF networks are remodeled during cell migration, differentiation, and apoptosis.
• CRISPR models enable causal testing of IF gene variants in disease.
What Happens During intermediate filament?
Dimerization and Tetramer Formation
In simple terms: IF proteins first pair up and then join into larger building blocks.
Intermediate filament assembly begins with the formation of coiled-coil dimers through parallel association of two IF protein monomers. These dimers then associate in an antiparallel fashion to form tetramers, which are the soluble building blocks of the filament. This step is driven by specific molecular interactions within the central alpha-helical rod domain.
Lateral Association and Filament Elongation
In simple terms: Tetramers stack side by side to form the long 10 nm filament.
Tetramers undergo lateral association and end-to-end annealing to form unit-length filaments, which then elongate into mature 10 nm intermediate filaments. This process is largely independent of nucleotide hydrolysis and is reversible under regulatory control.
Network Integration and Cytolinker Binding
In simple terms: Plectin and other proteins connect IFs to each other and to other cell structures.
Plectin, a large cytolinker, mediates the integration of intermediate filaments with each other and with other cytoskeletal systems, including actin and microtubules. Plectin isoforms determine the specific functions and localization of IF networks in different tissues.
Dynamic Remodeling and Phosphorylation
In simple terms: IFs can be taken apart and rebuilt, often controlled by chemical tags.
Intermediate filament dynamics involve phosphorylation-dependent disassembly and reassembly, allowing cells to remodel their IF networks during mitosis, migration, and stress responses. These dynamic changes are essential for cellular adaptation and are regulated by multiple kinases.
Key Genes Involved in GO:0005882 intermediate filament
The following genes encode major intermediate filament proteins and associated factors, representing the five classes and key regulatory components.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KRT14 | Type I acidic keratin; basal epidermal keratin | Mutations cause epidermolysis bullosa simplex |
| KRT5 | Type II basic keratin; basal epidermal keratin | Mutations cause epidermolysis bullosa simplex |
| KRT1 | Type II basic keratin; suprabasal keratin | Mutations cause epidermolytic hyperkeratosis |
| KRT10 | Type I acidic keratin; suprabasal keratin | Mutations cause epidermolytic hyperkeratosis |
| DES | Type III desmin; muscle-specific IF | Mutations cause desmin-related myopathy |
| VIM | Type III vimentin; mesenchymal IF | Biomarker and regulator of cell migration |
| GFAP | Type III glial fibrillary acidic protein | Astrocyte marker; linked to Alexander disease |
| NEFL | Type IV neurofilament light chain | Axonal structure; linked to Charcot-Marie-Tooth disease |
| NEFM | Type IV neurofilament medium chain | Axonal structure; neurodegeneration research |
| NEFH | Type IV neurofilament heavy chain | Axonal structure; neurodegeneration research |
| LMNA | Type V lamin A/C; nuclear lamina | Mutations cause laminopathies |
| LMNB1 | Type V lamin B1; nuclear lamina | Nuclear envelope integrity; disease links |
| PLEC | Plectin; cytolinker for IFs | Mutations cause epidermolysis bullosa with muscular dystrophy |
| KRT8 | Type II basic keratin; simple epithelia | Marker for epithelial cancers |
| KRT18 | Type I acidic keratin; simple epithelia | Marker for epithelial cancers |
| KRT19 | Type I acidic keratin; simple epithelia | Biomarker in cancer diagnostics |
| KRT7 | Type II basic keratin; glandular epithelia | Biomarker in cancer diagnostics |
| KRT20 | Type I acidic keratin; intestinal epithelia | Biomarker in colorectal cancer |
How Is intermediate filament Regulated?
Intermediate filament assembly and dynamics are regulated by phosphorylation, which controls filament disassembly and reassembly during cell cycle progression, migration, and stress responses. Plectin isoforms further regulate IF network organization and function in a tissue-specific manner. Additionally, IF expression is regulated at the transcriptional level in a tissue-specific fashion, contributing to the distinct IF profiles of different cell types.
intermediate filament and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KRT14 | Epidermolysis bullosa simplex | Knockout or point-mutation keratinocytes |
| DES | Desmin-related myopathy | Knockout or knock-in mouse models |
| LMNA | Laminopathies (muscular dystrophy, progeria) | Point-mutation or knockout iPSCs |
| NEFL | Charcot-Marie-Tooth disease | Knockout or point-mutation neuronal models |
| GFAP | Alexander disease | Knock-in or overexpression astrocyte models |
Intermediate Filament Myopathies
Mutations in desmin (DES) and other IF genes cause intermediate filament-related myopathies, characterized by muscle weakness and structural abnormalities. These disorders include desmin-related myopathy and other myofibrillar myopathies, where disrupted IF networks impair muscle integrity.
Skin Diseases
Mutations in keratin genes such as KRT5 and KRT14 cause epidermolysis bullosa simplex, a skin blistering disorder, while KRT1 and KRT10 mutations cause epidermolytic hyperkeratosis. These diseases highlight the critical mechanical role of IFs in epidermal integrity.
Neurodegeneration and Neuropathies
Neurofilament proteins (NEFL, NEFM, NEFH) are implicated in Charcot-Marie-Tooth disease and other neurodegenerative conditions. GFAP mutations cause Alexander disease, a fatal astrocyte disorder.
Laminopathies
Mutations in LMNA and LMNB1 cause laminopathies, including muscular dystrophy, lipodystrophy, and premature aging syndromes. These disorders underscore the role of Type V lamins in nuclear integrity and gene regulation.
From intermediate filament-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DES cause myopathy? | DES knockout cell or mouse model |
| Does a specific KRT14 mutation cause skin blistering? | KRT14 point-mutation knock-in keratinocytes |
| How does LMNA mutation affect nuclear integrity? | LMNA knock-in iPSC-derived cells |
| Where does plectin localize in IF networks? | PLEC tagged knock-in with fluorescent tag |
| Does overexpression of vimentin alter migration? | VIM overexpression cell lines |
| Can CRISPR screen identify modifiers of IF assembly? | CRISPR library screening in IF-reporter cells |
How to Study the intermediate filament Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Electron microscopy | Filament diameter and ultrastructure | Confirming 10 nm IF formation |
| Super-resolution microscopy | IF network organization | Studying assembly and dynamics |
| Co-immunoprecipitation | Protein-protein interactions | Identifying IF-associated proteins |
| In vitro assembly assay | Filament formation kinetics | Dissecting assembly mechanism |
| CRISPR knockout | Gene function loss | Testing IF gene necessity |
| CRISPR knock-in | Mutant protein expression | Modeling disease mutations |
| RNA-seq | Transcriptional changes | Profiling IF gene expression |
| Immunohistochemistry | Protein localization and expression | Diagnosing tissue-specific diseases |
Imaging and Structural Analysis
Electron microscopy and super-resolution imaging reveal the 10 nm diameter and network architecture of intermediate filaments. Live-cell imaging of fluorescently tagged IF proteins tracks assembly dynamics.
Biochemical and Proteomic Approaches
Co-immunoprecipitation and mass spectrometry identify IF-associated proteins and post-translational modifications. In vitro assembly assays reconstitute filament formation from purified proteins.
Genetic and Genomic Methods
CRISPR knockout, point-mutation, and knock-in models enable causal testing of IF gene variants. RNA-seq and proteomics profile IF expression changes in disease models.
Biomarker and Diagnostic Applications
Immunohistochemistry using IF protein-specific antibodies is a reliable diagnostic tool for tissue-specific diseases. This approach is widely used in pathology for tumor classification and myopathy diagnosis.
How CRISPR Can Be Used to Study GO:0005882 intermediate filament
Knockout
CRISPR knockout of intermediate filament genes such as DES, KRT14, or LMNA enables researchers to test their necessity for cell and tissue integrity. Knockout models reveal compensatory mechanisms and disease phenotypes.
Point Mutation
Introducing disease-associated point mutations (e.g., in KRT14 or LMNA) via CRISPR base editing or homology-directed repair creates isogenic models to study mutation-specific effects. These models are valuable for dissecting dominant-negative mechanisms.
Knock-in
Knock-in of fluorescent tags or reporter cassettes into IF genes allows live-cell imaging of filament dynamics and localization. This approach is useful for tracking IF assembly in real time.
Overexpression
CRISPR activation or cDNA overexpression of IF genes such as VIM or GFAP enables gain-of-function studies. Overexpression models help determine whether increased IF protein levels drive pathological changes.
How EDITGENE Supports intermediate filament Research
Researchers studying intermediate filament-related genes often need to determine whether a candidate gene is causally involved in a specific cellular or disease phenotype. This requires precise genetic models that can isolate the contribution of individual IF genes and their variants. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for intermediate filament research.
Frequently Asked Questions About intermediate filament
What is GO:0005882 intermediate filament?
GO:0005882 is a cellular component ontology term describing a 10 nm cytoskeletal structure in the cytoplasm, composed of heterogeneous subunits that mechanically integrate the cytoplasmic space.
What genes are involved in intermediate filament?
Key genes include KRT5, KRT14, DES, VIM, GFAP, NEFL, NEFM, NEFH, LMNA, LMNB1, and PLEC, representing the five IF classes.
What are the five classes of intermediate filaments?
Type I acidic keratins, Type II basic keratins, Type III desmin/vimentin and others, Type IV neurofilaments, and Type V lamins.
How are intermediate filaments assembled?
Assembly proceeds via coiled-coil dimers, antiparallel tetramers, and lateral association into 10 nm filaments, regulated by phosphorylation.
What diseases are linked to intermediate filament mutations?
Diseases include epidermolysis bullosa simplex, desmin-related myopathy, laminopathies, and neuropathies such as Charcot-Marie-Tooth disease.
What is the role of plectin in intermediate filaments?
Plectin is a cytolinker that mediates IF network integration and connects IFs to other cytoskeletal systems.
How can CRISPR be used to study intermediate filaments?
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of IF gene function and disease variants.
What methods are used to study intermediate filaments?
Methods include electron microscopy, super-resolution imaging, co-immunoprecipitation, in vitro assembly assays, and CRISPR-based genetic models.
Why are intermediate filaments important biomarkers?
IF proteins are tissue-specific and stable, making them reliable immunohistological biomarkers for diagnosing multiple tissue-specific diseases.
What is the diameter of intermediate filaments?
Intermediate filaments are characteristically 10 nm in diameter.
Conclusion
GO:0005882 intermediate filament represents a fundamental cytoskeletal system with critical roles in cell mechanics, tissue integrity, and human disease. The five classes of IF proteins, their assembly mechanism, and their regulation by phosphorylation and cytolinkers such as plectin are well-defined through decades of research. Dysregulation of IF genes causes a wide spectrum of diseases, from skin blistering to myopathies and laminopathies, underscoring their clinical importance. Advances in CRISPR-based models now allow precise dissection of IF gene function and disease variants, accelerating both basic discovery and therapeutic development. Researchers can leverage these tools to uncover new insights into intermediate filament biology and translate them into clinical applications.
References
- 1. Banwell BL. 2001. Intermediate filament-related myopathies.. Pediatr Neurol 24(4):257-63 PMID: 11377099
- 2. Eriksson JE et al.. 1992. Intermediate filament dynamics.. Curr Opin Cell Biol 4(1):99-104 PMID: 1558758
- 3. Coulombe PA. 2022. Capturing intermediate filament networks.. Elife 11 PMID: 35377313
- 4. Doganyigit Z et al.. 2023. Intermediate filament proteins are reliable immunohistological biomarkers to help diagnose multiple tissue-specific diseases.. Anat Histol Embryol 52(5):655-672 PMID: 37329162
- 5. Parry DA et al.. 1992. Intermediate filament structure.. Curr Opin Cell Biol 4(1):94-8 PMID: 1373068
- 6. Kechagia Z et al.. 2024. Structural determinants of intermediate filament mechanics.. Curr Opin Cell Biol 89:102375 PMID: 38850681
- 7. Vermeire PJ et al.. 2021. Molecular Interactions Driving Intermediate Filament Assembly.. Cells 10(9) PMID: 34572105
- 8. Wiche G. 2021. Plectin-Mediated Intermediate Filament Functions: Why Isoforms Matter.. Cells 10(8) PMID: 34440923
